Dawid Nowak, PhD

Highlights

24

6 grants

Co-I
Growth suppressive and oncogenic transcriptional programs controlled by the androgen receptor in prostate cancer
National Cancer Institute · 2025–2030
R01CA297829-01
KP
Defining Evolution of Prostate Cancer Metastasis Under Therapeutic Pressure Using Recordable Barcode
Prostate Cancer Foundation · 2025–2028
25YOUN26
PI
"Novel Mouse Models for Quantitative Understanding of Baseline and Therapy-Driven Evolution of Prostate Cancer Metastasis"
National Cancer Institute · 2023–2028
R01CA272466-04
KP
Determining Metastatic Drivers of Pten/p53-Loss-Driven Prostate Cancer Using Evolving DNA Barcodes
U.S. Department of Defense · 2022–2026
W81XWH-22-1-0068
PI
Defining Evolutionary Trajectories Driving Prostate Cancer Metastases
American Cancer Society · 2021–2026
RSG-21-057-01-SCM
PI
Determining and Targeting Evolutionary Trajectories Driving Bladder Cancer
Starr Cancer Consortium · 2023–2025
SCC I16-0060

Completed grants (2)

KP
Weill Cornell Medicine (WCM) SPORE in Prostate Cancer
National Cancer Institute · 2017–2023
P50CA211024-01A1
PI
Addgene 705286
Addgene, Inc. · 2022–2023
Addgene 705286

Prostate Cancer Foundation Awards Grants to Weill Cornell Medicine Investigators
March 26, 2026
Six researchers from Weill Cornell Medicine have received Young Investigator Awards from the Prostate Cancer Foundation.
Dr. Matthew Greenblatt Awarded Paul-Gallin Trailblazer Prize for Bone Stem Cell Discoveries
August 21, 2025
The award recognizes Dr. Greenblatt's discovery of distinct types of bone-building stem cells in different parts of the body.
Innovative Model Provides Valuable Insights into Prostate Cancer Spread
September 23, 2024
A new preclinical model using CRISPR, an advanced technology that allows scientists to cut and edit genes, has given Weill Cornell Medicine researchers and their colleagues a deeper insight into how prostate cancer spreads or metastasizes.
Cancer Research Teams Awarded Grants from Starr Cancer Consortium
February 10, 2023
Five teams led by Weill Cornell Medicine scientists have been awarded funding from the Starr Cancer Consortium in its 16th annual grant competition.